Journey Medical (DERM) stock forecast for 2022
Last update: 05-19-2022, 16:47
Sector: HealthcareThe share price of Journey Medical Corp. (DERM) now
What analysts predict:: $11
52-week high/low: $10.2 / $3.04
50/200 Day Moving Average: $4.349 / $5.4
This figure corresponds to the average price over the previous 50/200 days. For Journey Medical stocks, the 50-day moving average is the resistance level today.
For Journey Medical stocks, the 200-day moving average is the resistance level today.
Are you interested in Journey Medical stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Journey Medical stock price in 2022. How much will one Journey Medical share be worth in 2022?
Is it worth taking profit / loss on Journey Medical stock now or waiting? What are analysts' forecasts for Journey Medical stock?
We forecast Journey Medical stock performance using neural networks based on historical data on Journey Medical stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Journey Medical stock prediction results are shown below and presented as a graph, table and text information.
Journey Medical stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Journey Medical analysts is $11.
Today 200 Day Moving Average is the resistance level (5.4 $).
50 Day Moving Average is the resistance level (4.349 $).
Historical and forecast chart of Journey Medical stock
The chart below shows the historical price of Journey Medical stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Journey Medical stock price can be found in the table below.
Journey Medical (DERM) Forecast for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun | 4.31 | 3.98 | 4.71 | 15.37 % |
| Jul | 4.89 | 4.32 | 5.14 | 15.85 % |
| Aug | 5.03 | 4.45 | 5.39 | 17.31 % |
| Sep | 4.97 | 4.34 | 5.31 | 18.26 % |
| Oct | 5.03 | 4.74 | 5.44 | 12.72 % |
| Nov | 4.69 | 4.25 | 5.10 | 16.62 % |
| Dec | 5.02 | 4.71 | 5.56 | 15.17 % |
Journey Medical information and performance
Journey Medical Corp. operates as a commercial-stage pharmaceutical company, which engages in developing, acquiring, licensing and commercializing of dermatology products. It s focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its sales and marketing model. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Journey Medical Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE, AZ, US
Market Capitalization: 60 662 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -4.32
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.276
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 0.269
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 11431600
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Journey Medical price target for 2021 by month
Target values for the price of one Journey Medical share for Jun 2022.
Pessimistic target level: 3.98
Optimistic target level: 4.71
Target values for the price of one Journey Medical share for Jul 2022.
Pessimistic target level: 4.32
Optimistic target level: 5.14
Target values for the price of one Journey Medical share for Aug 2022.
Pessimistic target level: 4.45
Optimistic target level: 5.39
Target values for the price of one Journey Medical share for Sep 2022.
Pessimistic target level: 4.34
Optimistic target level: 5.31
Target values for the price of one Journey Medical share for Oct 2022.
Pessimistic target level: 4.74
Optimistic target level: 5.44
Target values for the price of one Journey Medical share for Nov 2022.
Pessimistic target level: 4.25
Optimistic target level: 5.10
Target values for the price of one Journey Medical share for Dec 2022.
Pessimistic target level: 4.71
Optimistic target level: 5.56